Transcatheter arterial chemoembolization (TACE) is the most commonly used method for non-surgical treatment of liver cancer, and it is usually used as an adjuvant therapy in patients who have not developed intrahepatic metastases after surgical resection. Postoperative adjuvant TACE therapy may provide a prognostic benefit in liver cancer patients with high recurrence risk. This article reviews the research progress of adjuvant TACE therapy for liver cancer after radical resection.
经导管肝动脉化疗栓塞术（TACE）是肝细胞癌非手术治疗的最常用方法，并常被辅助性应用于外科切除术后尚未发生肝内转移的患者。对于具有高复发风险的患者，术后辅助性的TACE治疗可为其预后带来收益。现就术后辅助性TACE治疗的研究进展进行综述。.